Biopsy of small renal massess
The question as to whether to biopsy small renal masses [...]
Stereotactic radiosurgery for multiple kidney cancer brain metastases
A recent study published in Clinical Genitourinary Cancer has shown that [...]
Immunoscore system to predict kidney cancer patient outcomes
A recent study by researchers in China, and published in [...]
Surgery may not be the most appropriate frontline treatment for metastatic kidney cancer
Results of the phase 3 SURTIME trial comparing pretreatment with [...]
New prognostic factor for metastatic renal cell carcinoma
A retrospective study has shown that a high systemic immune-inflammation [...]
ESOU 2019: Adjuvant therapy after nephrectomy for high-risk renal cell carcinoma
The following presentations were given at the European Association of [...]
ESOU 2019: First-line treatment for metastatic renal cell carcinoma – where do we stand?
The following review of the literature for first-line treatment of [...]
ESOU 2019: Cytoreductive nephrectomy: Current recommendations
This review paper was presented at the European Association of [...]
Computer-designed interleukin 2 (IL 2) without the side effects?
Interleukin-2 (IL2) is a naturally-occurring biological therapy called a cytokine. [...]
European Commission approves nivolumab plus ipilimumab combination for first-line advanced RCC
The European Commission has approved the nivolumab plus ipilimumab combination [...]
